Quinolone Vigilance Foundation

The Quinolone Vigilance Foundation announces new Director.

admin — Fri, 18 May 2012 15:52:11 +0000

The Quinolone Vigilance Foundation announced that Ms. Rachel Brummert has been appointed as the new Director of the organization. She will replace David Melvin, who has stepped down due to employment changes. Ms. Brummert, who has a background in special education and substance abuse counseling, will oversee the general operation of the foundation. Her email address is rachel@saferpills.org

Quinolone Vigilance Foundation Announces Board Secretary Position

admin — Sun, 22 Apr 2012 02:03:20 +0000

The Quinolone Vigilance Foundation is pleased to announce that Ms. Rachel Brummert has been appointed to the foundation board serving as the Corporate Secretary. Ms. Brummert, who has a background in special education and substance abuse counseling, will oversee the foundation’s business record keeping. Ms. Brummert, who has been personally impacted by quinolone toxicity, brings a wealth of experience to this position.

Quinolone Vigilance Foundation Announces Document Library Editor

admin — Sun, 22 Apr 2012 01:51:45 +0000

The Quinolone Vigilance Foundation is pleased to announce that Mr. Greg Spooner has accepted the position of Document Library Editor. Mr. Spooner will oversee the newly created quinolone document link library that will be populated with categorized and searchable links to quinolone research documents. Mr. Spooner will be populating the library during the upcoming months. He can be reached at greg@saferpills.org. The link library can be located at http://www.saferpills.org/?page_id=694

Neuropsychiatric Research Grant Data Collection Concluded

admin — Tue, 28 Feb 2012 17:21:18 +0000

The collection period for gathering neuropsychiatric research grant data has concluded. The information will be compiled by the academic institution to assist with a research grant into neurophyschiatric adverse events of fluoroquinolones. To those who participated, thank you.

Please stay tuned for upcoming informational gathering surveys. These surveys are encouraging initial steps which show that we have successfully garnered the attention of the academic institution. They are used by the academic institution to map out research directions and/or apply for grant monies.

We anticipate a more comprehensive fluoroquinolone adverse event survey, by a different U.S. academic institution, to be released late spring or early summer of 2012. Again, please stay tuned for notification of the name of the institution and the data gathering procedure.

If you have not signed up to receive information from the QVF please go to our home page and “Sign up for Updates & News” in the far right hand column.

Thank you.

QVF Gathering Data for Fluorquinolone U.S. Academic Grant

admin — Thu, 20 Oct 2011 17:33:10 +0000

The QVF is currently gathering basic information for a U.S. academic institution that will be applying for a fluoroquinolone research grant focusing on neuropsychiatric symptoms as a result of the toxicity. All data collected will be forwarded directly to the academic institution. Response is strictly voluntary and information you provide will be used to populate statistical data for the grant application. If you wish to volunteer information please go to the following web page:

http://www.saferpills.org/?page_id=415

Quinolone Vigilance Foundation Mailing Address

admin — Tue, 23 Aug 2011 15:21:58 +0000

The Quinolone Vigilance Foundation, formed to battle the problem of quinolone toxicity in the world today, announces its new mailing address. The following address is for general mail:

Quinolone Vigilance Foundation
P.O. Box 111
Cullom, IL 60292-0111

Quinolone Vigilance Foundation Creates Ambassador Program

admin — Sat, 30 Jul 2011 02:54:59 +0000

The Quinolone Vigilance Foundation (QVF), which is being established as a non-profit foundation to combat the problem of quinolone toxicity, announces the creation of the foundation’s Ambassador Program. The Ambassador Program is designed to encourage individuals to serve as advocates and spokespersons to represent the cause of quinolone toxicity to their particular state, geographic region, or country. QVF ambassadors, simply put, are pro-bono volunteers who take positive action to support the QVF’s mission which is to “understand and reduce Quinolone Toxicity as a cause of human suffering in the world.” As a QVF Ambassador you can perform numerous duties including raising public awareness, networking with other quinolone victims, organizing support meetings, working with local media and elected officials, providing support to other victims, educating medical professionals, and identifying sources of possible funding.

QVF’s ambassadors must be familiar with quinolone toxicity and committed to fulfilling the QVF’s mission and exhibit integrity, courtesy, and respect when representing the QVF. As a QVF ambassador you will be provided with the most current information that the QVF has available on quinolone toxicity, when it becomes available, so that you may present a consistent message to those with whom you interact. If you are interested in the QVF Ambassador Program contact the Ambassador Coordinator Ms. Lori McCandlish at lori@saferpills.org

Quinolone Vigilance Foundation Announces Ambassador Coordinator Position

admin — Fri, 29 Jul 2011 00:09:33 +0000

Ambassador Coordinator

We are pleased to announce that Lori McCandlish has been selected for the QVF Ambassador Coordinator position. Ms. McCandlish will oversee the foundation’s newly created “Ambassador Program,” which has been designed to encourage individuals to serve as advocates. Each “ambassador” will represent the cause of quinolone toxicity within his/her particular state, geographic region, or country. Ms. McCandlish, has been personally impacted by quinolone toxicity, and brings a wealth of knowledge to this position. If you are interested in becoming an ambassador for your area (or wish to learn more about the program in general), she can be reached atlori@saferpills.org.

Help Wanted

admin — Sat, 30 Apr 2011 00:44:36 +0000

The Quinolone Vigilance Foundation (QVF), which is being formed as a national nonprofit to combat quinolone toxicity, is looking for individuals to help or serve in the following positions:

Board Positions:

• Vice president
• Corporate secretary (Job description is here)
• Medical Doctor to serve as a board member/medical field liaison.

Other Positions:

• Experienced grant writers.
• Volunteers to serve on a fundraising committee.

If you are interested in any of the above positions please contact David Melvin. Please let David know what position you are interested in, any strengths that you have, and any resources that you may want to employ to help us fulfill our mission. Please note that all positions in the Quinolone Vigilance Foundation are strictly pro bono. No one receives compensation for their duties other than a feeling of satisfaction for contributing to a good cause.

We Must Unite

admin — Fri, 22 Apr 2011 03:36:06 +0000

People in the FQ community are confronted with all types of injustice. After a while they can get mentally and physically worn down and say, “that’s just the way things are.” They give in to the dominant narrative of the FQ culture that says that others have power but we do not. The ‘others’ could be medical professionals, corporations, or politicians. When the assumption of “that’s just the way things are” is believed it normalizes the existing power structure and makes it appear unchangeable.

The Quinolone Vigilance Foundation seeks to unite all those in the FQ community and focus our energy toward shared goals. To accomplish these goals we must be willing to take risks and have a vision of what our community can look like with our goals accomplished. Others in the community have started to take historic steps to forge new inroads into the medical research community, but these were only first steps. To succeed, our entire community must unite, despite our differences, and resist the despair and overcome the apathy.

David Melvin